Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thalidomide effect on ovarian reserve in IBD
NCT02998827Unknown
- Sponsor
- The Sixth Affiliated Hospital of Sun Yat-Sen University
- Start
- Nov 2016
- Primary completion
- Nov 2017
- Modality
- Small Molecules
01
Overview
Open-label trial of thalidomide in Crohn's disease (CD) (2 arms), sponsored by The Sixth Affiliated Hospital of Sun Yat-Sen University. Primary endpoints: Anti-Mullerian Hormone at 1 year, Antral Follicle Count at 1 year and 2 more. Status: unknown.
02
Drugs
thalidomide
03
Conditions
Crohn's disease (CD)
Beyond the preview
Go deeper on NCT02998827.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02998827.